Health systems face growing pressure to rethink how and where they provide infusion services. To protect volumes and margin amid payer site-of-care requirements, policy reforms, and an evolving drug pipeline, health systems should evaluate their ambulatory infusion capabilities. This report offers actionable guidance for leaders to assess market dynamics, set clear infusion goals, and select the right ambulatory infusion model for their businesses.